Growth Opportunities in the Global Sleep Apnea Devices Market 2017: Segmented by Product type, Treatment Devices, End-User and Geography – Growth, Trends, and Forecasts (2017 – 2024)

“Major Players Operating in this market are Koninklijke Philips N.V. , Natus Medical Incorporated, and Nihon Kohden along with others such as CareFusion Corporation, Curative Medical Inc., ResMed, Fisher and Paykel Healthcare Limited., SomnoMed, BMC Medica”
Global Sleep Apnea Devices Market, By Product Type (Diagnostic Devices (Polysomnographs, Pulse Oximeters, Polygraphs, Actygraph), Treatment Devices (PAP, Facial Interfaces, ASV, Airway Clearance Systems, Oxygen Concentrators, Oral Appliances, Accessories), By End-User (Hospitals, Home Healthcare, Sleep Clinics, Community Healthcare), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Global Sleep Apnea Devices Market has accounted for USD 3.9 billion in 2016, is expected to reach USD 7.1 billion by 2024 at a CAGR of 7.8% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024

Request for Sample @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-sleep-apnea-devices-market

Global Sleep Apnea Market – Drivers:

Some of the major factors driving the market for sleep apnea devices market aretechnological advancement, increasing prevalence of sleep apnea, rising geriatric population, and changing lifestyle, rising acceptance of home healthcare, increasing awareness of health, changing lifestyles, increasing aging population, rising prevalence of sleep disorder , improving diagnosis rates, introduction to new technologies which improves patient comfort, increasing healthcare spending, improving healthcare infrastructure, rising disposable income.

TECHNOLOGICAL ADVANCEMENT

Technological advancements in sleep apnea devices are on the rise. There are several companies developing advanced devices which stimulate the genioglossus muscle to keep pharyngeal airway open during sleep. Continuous positive airway pressure (CPAP) mask is considerably better than the previously developed devices and are responsible for the modest gains in CPAP compliance Start-up companies are developing more devices which are mostly adjustable and automatic.

INCREASING PREVALENCE OF SLEEP APNEA

Sleep apnea increases the risk of diseases such as heart attack, stroke, and diabetes. Sleep apnea is a disorder which halts breathing for a few seconds during sleep, this disorder occur when the tissues in the upper throat collapse during sleep due to various reasons such as blockage of air, insomnia, shift work, and snoring. Obstructive sleep apnea causes several heart problems like congestive heart failure, coronary artery disease, and irregular heartbeat.

RISING GERIATRIC POPULATION

The world population is ageing in almost every country. The proportion of people aged over 65 years is growing faster than any other age group and sleep apnea is a common disorder in old people and they are diagnosed less with OSA. Sleep apnea in the elderly is caused by increased fat deposits in the head and neck, and changes in body structure.

CHANGING LIFESTYLE

Nowadays, lifestyle of people is changing rapidly. People tend to have high intake of alcohol and drugs, smoking, obesity, unhealthy sleep patterns and postures, lack of awareness, and high stress levels can generate negative impact on health, digestion and immunity. Changing lifestyle and work pressure often leads to the improper diet which may further add to stress and tension in life. Because of busy schedule and hectic lives they are unable to live a healthy life style.

Browse Full Report @ http://databridgemarketresearch.com/reports/global-sleep-apnea-devices-market/

Global Sleep Apnea Devices Market – Segmentation:

On the basis of type, sleep apnea device market is categorized into: diagnostic devices and therapeutic devices. In 2017, diagnostic devices segment is expected to dominate the market with 60.3% market share.

Based on product type, the diagnostic sleep apnea device market is segmented into polysomnography devices, respiratory polygraphs, pulse oximeters and actigraph systems. Polysomnograph segment is expected to dominate the market in future along with the highest growing CAGR of 10.3% in the forecast period. On the basis of product type, the therapeutic sleep apnea devices are segmented into positive airway pressure devices (PAP), continuous positive airway pressure devices (CPAP), automatically adjusting positive airway pressure devices (APAP), masks, adaptive servo ventilation, airway clearance system, oxygen concentrators, oral appliances and accessories.

On the basis of end users, the global sleep apnea devices market is further segmented into hospitals, sleep clinics, community healthcare and home healthcare. In 2017, the hospitals segment dominates the global sleep apnea device market.

Ask For TOC: http://databridgemarketresearch.com/toc/?dbmr=global-sleep-apnea-devices-market

Based on geography the market is segmented into 5 geographical regions such as North America, Europe, Asia-Pacific, South America, Middle East and Africa. The geographical regions are further segmented into major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan,China, Singapore, Brazil, India, Russia, South Africa.

The Global Sleep Apnea Devices Market Report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.

Global Sleep Apnea Devices Market – Company Overview:

Koninklijke Philips N.V. dominated the sleep apnea devices market in 2016, followed by Natus Medical Incorporated, and Nihon Kohden along with others such as CareFusion Corporation, Curative Medical Inc., ResMed, Fisher and Paykel Healthcare Limited., SomnoMed, BMC Medical Co., Ltd., Compumedics Limited, NatusMedical Inc., DeVilbiss Healthcare, Global Medical Holdings, Itamar Medical Ltd., Weinmann Medical Technology, Cleveland Medical Devices Inc., SOMNOmedics GmbH, Deymed Diagnostic, NovaSom, and Medtronic.

For an Analyst Call: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-sleep-apnea-devices-market

Table OF Content:

1. INTRODUCTION

       1.1. OVERVIEW OF THE SLEEP APNEA DEVICES MARKET

       1.2. MARKET SEGMENTATION & COVERAGE

                1.2.1. CURRENCY AND PRICING

                1.2.2. LIMITATION

2. RESEARCH METHODOLOGY

       2.1. KEY TAKEAWAYS

       2.2. ARRIVING AT THE GLOBAL SLEEP APNEA DEVICES MARKET SIZE

                2.2.1. MARKET CRACKDOWN APPROACH

                2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

                2.2.3. DATA TRIANGULATION

                2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

                 2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES

                2.2.6. PORTER’S FIVE FORCES MATRIX

                2.2.7. PEST ANALYSIS

       2.3. ASSUMPTIONS

       2.4. GLOBAL SLEEP APNEA DEVICES MARKET: RESEARCH SNAPSHOT

3. MARKET LANDSCAPE SUMMARY

4. PREMIUM INSIGHTS

       4.1. OVERVIEW

       4.2. SLEEP APNEA DEVICES MARKET: KEY PRIMARY INSIGHTS

       4.3. MARKET OVERVIEW

                4.3.1. DRIVER

                4.3.2. RESTRAINTS

                4.3.3. OPPURTUNITIES

                4.3.4. THREATS

       4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5. SLEEP APNEA DEVICES MARKET, BY TYPE

       5.1. OVERVIEW

       5.2. SLEEP APNEA THERAPEUTIC DEVICES

       5.3. SLEEP APNEA DIAGNOSTIC DEVICES

6. SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT TYPE

       6.1. OVERVIEW

       6.2. POSITIVE AIRWAY PRESSURE DEVICES MARKET (PAP)

                6.2.1. CONTINUOUS AIRWAY PRESSURE DEVICES MARKET (CPAP)

                6.2.2. BI-LEVEL AIRWAY PRESSURE DEVICES MARKET (BIPAP)

                6.2.3. VARIABLE POSITIVE AIRWAY PRESSURE (VPAP)

                6.2.4. AUTOMATICALLY-ADJUSTING POSITIVE AIRWAY PRESSURE (APAP)

       6.3. MASKS

                6.3.1. NON-VENTED MASKS

                6.3.2. NASAL MASKS

                6.3.3. NASAL PILLOWS

                6.3.4. FULL FACE MASKS

                6.3.5. PAEDIATRIC MASKS

                6.3.6. OTHERS

       6.4. ADAPTIVE SERVO-VENTILATION (ASV)

       6.5. AIRWAY CLEARANCE SYSTEMS

       6.6. OXYGEN CONCENTRATORS

                6.6.1. STATIONARY CONCENTRATORS

                6.6.2. PORTABLE CONCENTRATORS

       6.7. ORAL SLEEP APNEA DEVICES

                6.7.1. MANDIBULAR ADVANCEMENT DEVICES (MAD)

                6.7.2. TONGUE RETAINING DEVICE (TRD)

       6.8. ACCESSORIES

7. SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT TYPE

       7.1. OVERVIEW

       7.2. PULSE OXIMETERS

                7.2.1. HANDHELD PULSE OXIMETERS

                7.2.2. FINGERTIP PULSE OXIMETERS

                7.2.3. TABLETOP PULSE OXIMETERS

                7.2.4. WRIST-WORN PULSE OXIMETERS

       7.3. POLYSOMNOGRAPH (PSG)

                7.3.1. CLINICAL PSG

                7.3.2. AMBULATORY PSG DEVICES

       7.4. RESPIRATORY POLYGRAPH

       7.5. ACTIGRAPH

8. SLEEP APNEA DEVICES MARKET, BY END USER

       8.1. OVERVIEW

       8.2. HOSPITALS

       8.3. HOME HEALTHCARE

       8.4. SLEEP CLINICS

       8.5. COMMUNITY HEALTHCARE

9. SLEEP APNEA DEVICES MARKET, BY APNEA TYPE

       9.1. OBSTRUCTIVE SLEEP APNEA

                9.1.1. PATIENT VOLUME

                9.1.2. MARKET SIZE

       9.2. CENTRAL SLEEP APNEA

                9.2.1. PATIENT VOLUME

                9.2.2. MARKET SIZE

       9.3. COMPLEX SLEEP APNEA

                9.3.1. PATIENT VOLUME

                9.3.2. MARKET SIZE

10. SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY

       10.1. COUNTRYWISE SLEEP APNEA DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

                10.1.1. NORTH AMERICA

                             10.1.1.1. U.S.

                             10.1.1.2. CANADA

                             10.1.1.3. MEXICO

                10.1.2. EUROPE

                             10.1.2.1. GERMANY

                             10.1.2.2. FRANCE

                             10.1.2.3. U.K.

                             10.1.2.4. ITALY

                             10.1.2.5. SPAIN

                             10.1.2.6. RUSSIA

                             10.1.2.7. TURKEY

                             10.1.2.8. BELGIUM

                             10.1.2.9. NETHERLANDS

                             10.1.2.10. SWITZERLAND

                             10.1.2.11. REST OF EUROPE

                10.1.3. ASIA-PACIFIC (APAC)

                             10.1.3.1. JAPAN

                             10.1.3.2. CHINA

                             10.1.3.3. SOUTH KOREA

                             10.1.3.4. INDIA

                             10.1.3.5. AUSTRALIA

                             10.1.3.6. SINGAPORE

                             10.1.3.7. THAILAND

                             10.1.3.8. MALAYSIA

                             10.1.3.9. INDONESIA

                             10.1.3.10. PHILIPPINES

                             10.1.3.11. REST OF APAC

                10.1.4. SOUTH AMERICA

                             10.1.4.1. BRAZIL

                             10.1.4.2. REST OF LATIN AMERICA

                10.1.5. MIDDLE EAST AND AFRICA

                             10.1.5.1. SAUDI ARABIA

                             10.1.5.2. REST OF MIDDLE EAST AND AFRICA

       10.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

11. SLEEP APNEA DEVICES MARKET: COMPETITIVE LANDSCAPE

       11.1. GLOBAL SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS

       11.2. U.S. SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS

       11.3. EUROPE SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS

       11.4. APAC SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS

       11.5. MERGERS & ACQUISITIONS 

       11.6. NEW PRODUCT DEVELOPMENT & APPROVALS

       11.7.  EXPANSIONS

       11.8. REGULATORY CHANGES

       11.9. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

12. SLEEP APNEA DEVICES MARKET, COMPANY PROFILES

       12.1. PHILIPS RESPIRONICS

                12.1.1. OVERVIEW

                12.1.2. SWOT ANALYSIS

                12.1.3. PRODUCT PORTFOLIO

                12.1.4. REVENUE ANALYSIS

                12.1.5. ANALYSTS VIEW

       12.2. RESMED

                12.2.1. OVERVIEW

                12.2.2. SWOT ANALYSIS

                12.2.3. PRODUCT PORTFOLIO

                12.2.4. REVENUE ANALYSIS

                12.2.5. ANALYSTS VIEW

       12.3. FISHER AND PAYKEL HEALTHCARE, LTD.

                12.3.1. OVERVIEW

                12.3.2. SWOT ANALYSIS

                12.3.3. PRODUCT PORTFOLIO

                12.3.4. REVENUE ANALYSIS

                12.3.5. ANALYST VIEW

       12.4. COMPUMEDICS LIMITED

                12.4.1. OVERVIEW

                12.4.2. SWOT ANALYSIS

                12.4.3. PRODUCT PORTFOLIO

                12.4.4. REVENUE ANALYSIS

                12.4.5. ANALYSTS VIEW

       12.5. SOMNOMED

                12.5.1. OVERVIEW

                12.5.2. SWOT ANALYSIS

                12.5.3. PRODUCT PORTFOLIO

                12.5.4. REVENUE ANALYSIS

                12.5.5. ANALYSTS VIEW

       12.6. CAREFUSION CORPORATION

                12.6.1. OVERVIEW

                12.6.2. SWOT ANALYSIS

                12.6.3. PRODUCT PORTFOLIO

                12.6.4. REVENUE ANALYSIS

                12.6.5. NALYSTS VIEW

       12.7. CURATIVE MEDICAL, INC.

                12.7.1. OVERVIEW

                12.7.2. SWOT ANALYSIS

                12.7.3. PRODUCT PORTFOLIO

                12.7.4. REVENUE ANALYSIS

                12.7.5. ANALYSTS VIEW

       12.8. BMC MEDICAL, CO. LTD.

                12.8.1. OVERVIEW

                12.8.2. SWOT ANALYSIS

                12.8.3. PRODUCT PORTFOLIO

                12.8.4. REVENUE ANALYSIS

                12.8.5. ANALYSTS VIEW

       12.9. NATUS MEDICAL, INC.

                12.9.1. OVERVIEW

                12.9.2. SWOT ANALYSIS

                12.9.3. PRODUCT PORTFOLIO

                12.9.4. REVENUE ANALYSIS

                12.9.5. ANALYSTS VIEW

       12.10. DEVILBISS HEALTHCARE

                12.10.1. OVERVIEW

                12.10.2. SWOT ANALYSIS

                12.10.3. PRODUCT PORTFOLIO

                12.10.4. REVENUE ANALYSIS

                12.10.5. ANALYSTS VIEW

       12.11. GLOBAL MEDICAL HOLDINGS, LLC

                12.11.1. OVERVIEW

                12.11.2. SWOT ANALYSIS

                12.11.3. PRODUCT PORTFOLIO

                12.11.4. REVENUE ANALYSIS

                12.11.5. ANALYSTS VIEW

       12.12. ITAMAR MEDICAL, LTD.

                12.12.1. OVERVIEW

                12.12.2. SWOT ANALYSIS

                12.12.3. PRODUCT PORTFOLIO

                12.12.4. REVENUE ANALYSIS

                12.12.5. ANALYSTS VIEW

       12.13. WEINMANN MEDICAL DEVICES GMBH & CO. KG

                12.13.1. OVERVIEW

                12.13.2. SWOT ANALYSIS

                12.13.3. PRODUCT PORTFOLIO

                12.13.4. REVENUE ANALYSIS

                12.13.5. ANALYSTS VIEW

       12.14. SIBELGROUP

                12.14.1. OVERVIEW

                12.14.2. SWOT ANALYSIS

                12.14.3. PRODUCT PORTFOLIO

                12.14.4. REVENUE ANALYSIS

                12.14.5. ANALYSTS VIEW

       12.15. AMBULATORY MONITORING, INC.

                12.15.1. OVERVIEW

                12.15.2. SWOT ANALYSIS

                12.15.3. PRODUCT PORTFOLIO

                12.15.4. REVENUE ANALYSIS

                12.15.5. ANALYSTS VIEW

       12.16. MEDICOM MTD, LTD.

                12.16.1. OVERVIEW

                12.16.2. SWOT ANALYSIS

                12.16.3. PRODUCT PORTFOLIO

                12.16.4. REVENUE ANALYSIS

                12.16.5. NALYSTS VIEW

       12.17. CUSTO MED GMBH

                12.17.1. OVERVIEW

                12.17.2. SWOT ANALYSIS

                12.17.3. PRODUCT PORTFOLIO

                12.17.4. REVENUE ANALYSIS

                12.17.5. ANALYSTS VIEW

       12.18. HEINEN LOWENSTEIN GMBH & CO. KG

                12.18.1. OVERVIEW

                12.18.2. SWOT ANALYSIS

                12.18.3. PRODUCT PORTFOLIO

                12.18.4. REVENUE ANALYSIS

                12.18.5. ANALYSTS VIEW

       12.19. ERGOLINE GMBH

                12.19.1. OVERVIEW

                12.19.2. SWOT ANALYSIS

                12.19.3. PRODUCT PORTFOLIO

                12.19.4. REVENUE ANALYSIS

                12.19.5. ANALYSTS VIEW

       12.20. NEUROVIRTUAL

                12.20.1. OVERVIEW

                12.20.2. SWOT ANALYSIS

                12.20.3. PRODUCT PORTFOLIO

                12.20.4. REVENUE ANALYSIS

                12.20.5. ANALYSTS VIEW

       12.21. BMC MEDICAL CO., LTD.

                12.21.1. OVERVIEW

                12.21.2. SWOT ANALYSIS

                12.21.3. PRODUCT PORTFOLIO

                12.21.4. REVENUE ANALYSIS

                12.21.5. ANALYSTS VIEW

       12.22. SOMNOMEDICS GMBH

                12.22.1. OVERVIEW

                12.22.2. SWOT ANALYSIS

                12.22.3. PRODUCT PORTFOLIO

                12.22.4. REVENUE ANALYSIS

                12.22.5. ANALYSTS VIEW

       12.23. CONTEC MEDICAL SYSTEMS CO.,LTD.

                12.23.1. OVERVIEW

                12.23.2. SWOT ANALYSIS

                12.23.3. PRODUCT PORTFOLIO

                12.23.4. REVENUE ANALYSIS

                12.23.5. ANALYSTS VIEW

       12.24. CLEVELAND MEDICAL DEVICES INC.

                12.24.1. OVERVIEW

                12.24.2. SWOT ANALYSIS

                12.24.3. PRODUCT PORTFOLIO

                12.24.4. REVENUE ANALYSIS

                12.24.5. ANALYSTS VIEW

       12.25. SOMNETICS INTERNATIONAL, INC.

                12.25.1. OVERVIEW

                12.25.2. SWOT ANALYSIS

                12.25.3. PRODUCT PORTFOLIO

                12.25.4. REVENUE ANALYSIS

                12.24.5. ANALYSTS VIEW

13. APPENDIX

       13.1. RELATED REPORTS

       13.2. CUSTOMIZABLE OPTIONS

       13.3. SOURCE SHEET

       13.4. BIBLIOGRAPHY

14. ABOUT DATA BRIDGE MARKET RESEARCH

Related Report

Europe Sleep Apnea Devices Market – Industry Trends and Forecast to 2024

Europe Sleep Apnea Devices Market, By Product Type, By End-Users, By Distribution Channel, By Country (Germany, France, United kingdom, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe) – Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/europe-sleep-apnea-devices-market/

Contact:

Vishal Dixit

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Investor:investors@databridgemarketresearch.com

Visit Blog http://databridgemarketresearch.com/blog/  

Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Vishal Dixit
Email: Sales@databridgemarketresearch.com
Phone: +1-888-387-2818
Address:Office Number 317, Amanora Chambers, Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-sleep-apnea-devices-market/